Severely crack down on the phenomenon of buying and selling platform accounts through abnormal means (securities firms, underwriters, and enterprises relying on large, medium, and small financial institutions), and report that some securities firms use undisclosed important information to buy and sell platform accounts, thereby profiting before other investo...
Lavay, New Jersey and New York -- (Business Wire) -- Merck&Co. (NYSE: MRK) (referred to as MSD outside of the United States and Canada) announced today that the registration of "Merck&Co." based on MSD China has been completed. The publication application covers Standard&Poor's rating criteria for Merck&Co., based on Merck's short-term financ...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the National Medical Products Administration (NMPA) of China approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for use in males 9-26 years of age to help prevent cer...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at the 43rd Annual J.P. Morgan Hea...
If you have any questions, please contact our team. [email protected] ...
The main executive office of the company is located at: 126 East Lincoln Avenue PO Box 2000 Rahway, NJ 07065 United States ...
PwC Accounting Firm Florum Park, New Jersey, USA...
The best way to contact the company's investor relations department is through email [email protected] ...
Global sales in the fourth quarter were $15.6 billion, an increase of 7% compared to the fourth quarter of 2023; Excluding the impact of foreign exchange, the growth rate is 9% GAAP earnings per share for the fourth quarter were $1.48; Non GAAP earnings per share of $1.72; Both GAAP and non GAAP earnings per share include an expense of $0.23 per share relat...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the closing of the exclusive global license agreement for LM-299, a novel investigational PD-1/VEGF bispecific antibody, from LaNova Medicines Ltd. As previously announced, Merck will develop, manufacture and commercialize LM-...